The CFO and CEO Dinner is sold out. Please contact Molly Corrigan ([email protected]) to be placed on the waitlist.
*This event is reserved for Life Sciences Pennsylvania Core Member Companies. This invitation is only for those who serve in the capacity of chief executive officer or chief financial officer of a Core member company. If you are not sure of your eligibility, please contact Lois Stephens, Membership Manager, [email protected].
*There is no registration fee. The cost for this event is fully underwritten by our generous sponsors. However, space is limited and you must register for this event if you plan to attend
Join us at Flourtown Country Club for a relaxed evening to meet new colleagues, reconnect with those familiar, and to hear our guest speaker.
Where: Flourtown Country Club
When: Wednesday, November 14, 2018
Time: 6:00 PM - 8:30 PM
ANDREW SCHIFF, MD
Managing Partner, Aisling Capital
Dr. Schiff joined Aisling in September of 1999 and currently serves as one of the Managing Partners. Prior to Aisling Capital, Dr. Schiff practiced internal medicine for six years at The New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine.
Dr. Schiff currently serves as a director of Aclaris Therapeutics, ARMGO Pharma, and PowerVision, and as a Board observer of Harmony Biosciences and Zavante Therapeutics. Previously, he served as a director of Adams Respiratory Therapeutics, Agile Therapeutics, ArgiNOx Pharmaceuticals, Barrier Therapeutics, Bioenvision, CardioKine, Cempra Pharmaceuticals, Miramar Labs, Myogen, SkinMedica, Sirion Therapeutics, TransEnterix, ZELTIQ Aesthetics, and Quintiles (Board observer). He is a longtime supporter and Board member of the Visiting Nurse Service of New York.
Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia Business School, and his B.S. with honors in Neuroscience from Brown University.